Sign In
By signing in or creating an account, you agree with Associated Broadcasting Company's Terms & Conditions and Privacy Policy.
By signing in or creating an account, you agree with Associated Broadcasting Company's Terms & Conditions and Privacy Policy.
Kolkata: Nephrocare Health Services IPO bidding process is beginning today, Dec 10. It runs services under the brand NephroPlus and the issue is designed to raise Rs 871.05 crore via a combination of fresh issue of 0.77 crore shares aggregating to Rs 353.40 crore and an OFS part of 1.13 crore shares amounting to Rs 517.64 crore.
Nephrocare Health Services IPO managed to raise Rs 260 crore from anchor investors, the company informed the bourses on Dec 9. Some of the anchor investors were prominent AMCs such as SBI Mutual Fund (MF), ICICI Prudential MF, Fidelity Funds, DSP MF, Bandhan MF, The Prudential Assurance Company, Eastspring Investments, Polar Capital Funds, Baroda BNP Paribas MF, SBI Life Insurance and HDFC Life Insurance. The company placed a total of 56.58 lakh shares to 14 mutual funds at Rs 460 apiece.
According to investorgain, Nephrocare Health IPO GMP has failed to take off at all from the level of zero. Considering the upper band of the price band of Rs 460, the GMP signalled a listing gain of zero. However, a significant point to note is that GMP, is only an unofficial indicators that can be extremely volatile. Also it cannot guarantee any listing gain (or loss).
The Nephrocare Health IPO price band has been set at Rs 438-460. The minimum investible lot for a retail investor to bid for is 32 shares and it demands an application money of Rs 14,720 based on the upper price. The smallest lot size for investment by sNII investors is 14 lots or 448 shares and that by bNII investors is 68 lots or 2,176 shares. ICICI Securities is the book running lead manager and Kfin Technologies the registrar to the issue.
IPO bid opens: Dec 10, 2025
IPO bid closes: Dec 12
Cut-off time for UPI mandate confirmation: Dec 12
Allotment: Dec 15
Refund: Dec 16
Credit of shares to demat: Dec 16
Listing: Dec 17
The company was set up in 2010 and it provides dialysis care through a network of clinics across the country and a few international markets. The services it offers include diagnosis, haemodialysis, home and mobile dialysis and wellness programs as well as in-house pharmacy. As on September 30 2025, Nephrocare ran 519 clinics of which 51 were located in the Philippines, Uzbekistan and Nepal. In India, the services are present in 288 cities in 21 States and 4 Union Territories. In FY25, Nephrocare served 29,281 patients and completed 2,885,450 dialysis treatments, which is reportedly about 10% of the country's total dialysis patients.
(Disclaimer: This article is only meant to provide information. TV9 does not recommend buying or selling shares or subscriptions of any IPO, Mutual Funds, precious metals, commodity, any form of alternative investment instruments and crypto assets.)
